Searchable abstracts of presentations at key conferences in endocrinology

ea0041oc7.2 | Cardiovascular endocrinology | ECE2016

Cardiovascular and metabolic morbidity in adult patients with classic congenital adrenal hyperplasia

Paizoni Luisa , Schaefer Kerstin , Thomas Evelina , Reisch Nicole

Background: Several studies suggest health problems in adult patients with CAH. However, data is inconsistent and based on small and relatively young cohorts.The aim of this study was to analyze the metabolic and cardiovascular health in a cohort of 90 adult patients with classic CAH.Subjects and methods: Participants included 90 patients with classic CAH: age range 18–62 years (mean 32.9±10.5, median 29.2) 39 male, 51 fe...

ea0016p384 | Neuroendocrinology | ECE2008

Hypothalamic–pituitary insufficiency following infectious diseases of the central nervous system

Schaefer Stephan , Boegershausen Nina , Meyer Silke , Ivan Diana , Schepelmann Karsten , Kann Peter Herbert

Hypothalamic–pituitary insufficiency may have diverse causes. Infectious diseases of the central nervous system (CNS) may also affect the hypothalamus and/or the pituitary, although this has not been reported very often and not yet been studied systematically. It was the aim of this study to determine the incidence of hypothalamic–pituitary insufficiency in patients with previous infectious diseases of the CNS of different etiology.Patient seri...

ea0041gp15 | Adrenal (1) | ECE2016

Reduced temperature and the chemical chaperone 4-phenylbutyrate enhance stability of CYP21A2 mutations

Chen Yiqing , Schaefer Kerstin , Gasteiger Maria , Taylor Angela , Arlt Wiebke , Krone Nils , Gersting Soeren W. , Reisch Nicole

Background: Mutations of 21-hydroxylase (CYP21A2) cause congenital adrenal hyperplasia. Its severe (classic) form constitutes a life-threatening disease. Patients suffer a significant disease burden due to co-morbidities that are often treatment-related. The current therapeutic situation is unsatisfying and demands novel treatment approaches. In silico modelling suggests protein misfolding and intracellular retention to play a significant role in the pathogenesis of C...

ea0011p471 | Endocrine tumours and neoplasia | ECE2006

The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma

Fassnacht M , Koschker AC , Hahner S , Maeder U , Weismann D , Linden T , Quinckler M , Willenberg H , Bucsky P , Diehl S , Brauckhoff M , Schaefer M , Schlenz N , Muessig K , Reincke M , Allolio B

Objectives: The TNM classification is a worldwide benchmark for reporting the extent of malignant disease and is intended as a prognostic tool to predict the outcome in patients with cancer. Until 2004, no TNM classification was available for adrenocortical carcinoma (ACC) and different staging systems were used. Due to the rarity of this malignancy, the prognostic value of different staging systems has never been compared directly in a large series of patients.<p class="a...